Continue to site >
Trending ETFs

Baird Small/Mid Cap Growth Fund

mutual fund
BSGSX
Payout Change
Suspended
Price as of:
$17.14 -0.18 -1.04%
primary theme
U.S. Mid-Cap Growth Equity
share class
BSGSX (Mutual Fund)

Baird Small/Mid Cap Growth Fund

Payout Change
Suspended
Price as of:
$17.14 -0.18 -1.04%
primary theme
U.S. Mid-Cap Growth Equity
share class
BSGSX (Mutual Fund)

Baird Small/Mid Cap Growth Fund

Payout Change
Suspended
Price as of:
$17.14 -0.18 -1.04%
primary theme
U.S. Mid-Cap Growth Equity
share class

Name

As of 12/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$17.14

$182 M

0.00%

1.17%

Vitals

YTD Return

8.8%

1 yr return

8.8%

3 Yr Avg Return

-4.4%

5 Yr Avg Return

8.2%

Net Assets

$182 M

Holdings in Top 10

25.8%

52 WEEK LOW AND HIGH

$17.3
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 1.17%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 50.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$2,500

IRA

$1,000


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 12/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$17.14

$182 M

0.00%

1.17%

BSGSX - Profile

Distributions

  • YTD Total Return 8.8%
  • 3 Yr Annualized Total Return -4.4%
  • 5 Yr Annualized Total Return 8.2%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.88%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    Baird Small/Mid Cap Growth Fund
  • Fund Family Name
    Baird
  • Inception Date
    Oct 31, 2018
  • Shares Outstanding
    47675
  • Share Class
    Investor
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Jonathan Good

Fund Description

The Fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in the equity securities of U.S. and foreign small- and mid-capitalization companies, principally common stocks and American Depositary Receipts (“ADRs”) that are traded on major U.S. exchanges. Although the Fund principally invests in U.S. companies, the Fund may invest up to 15% of its total assets in equity securities (consisting of common stocks, ordinary shares and ADRs) of foreign companies. The Fund defines small- and mid-capitalization companies as those companies with a market capitalization within the range of companies in the Russell 2500® Growth Index at the time of investment.
When analyzing equity securities to be purchased by the Fund, the Advisor emphasizes a company’s growth prospects. The Fund’s investments are selected using a variety of both quantitative techniques and fundamental research in seeking to maximize the Fund’s expected return while controlling risk.
The Fund seeks a portfolio comprised of companies which reflect “PRIME” growth factors. These factors are analyzed as part of the Advisor’s investment process and are represented in the following ways:
Durable Profitability. Companies with advantaged competitive positions have greater potential to generate attractive and increasing margins, and high returns.
Sustainable Revenue Growth. Solid barriers to entry, favorable pricing power and an effective strategy can support top-line prospects, and superior earnings growth.
Favorable Industry dynamics. The Advisor leverages their intellectual capital by identifying favorable end market demand, making investment across sectors.
Strong Management. A critical element of a high-quality company. The Advisor seeks governance practices promoting integrity, accountability, and shareholder alignment. Growth, profitability, and balance sheet strength provide insight into effective management.
Market Expectations. Important in assessing risk/return opportunities and portfolio capital allocation. Strengthening fundamental trends can expand valuation potential.
The Advisor believes an analysis of these PRIME factors yields insights into the competitive strength of a business model.
The Advisor applies the following strategies when purchasing securities for the Fund’s portfolio:
Typically holding the securities of fewer than 70 companies with exposure to approximately 20 industries.
Seeking securities whose growth prospects, in the Advisor’s opinion, are not reflected in their current stock prices.
Limiting the size of any one new position. No security will represent more than 5% of the Fund’s total assets at the time of purchase.
The Advisor may sell a security when the price meets or exceeds the Advisor’s targeted valuation or price range for the security, when a significant change occurs that adversely affects the Advisor’s premise or reasons for investing in the security or when the company experiences a fundamental deterioration in its business, financial condition or results, or growth prospects.
Read More

BSGSX - Performance

Return Ranking - Trailing

Period BSGSX Return Category Return Low Category Return High Rank in Category (%)
YTD 8.8% -1.4% 93.8% 84.66%
1 Yr 8.8% -2.3% 102.5% 85.05%
3 Yr -4.4%* -15.1% 30.0% 87.84%
5 Yr 8.2%* -2.2% 101.1% 68.06%
10 Yr N/A* 2.3% 24.3% N/A

* Annualized

Return Ranking - Calendar

Period BSGSX Return Category Return Low Category Return High Rank in Category (%)
2023 10.6% -27.7% 68.0% 85.21%
2022 -27.8% -85.6% 52.8% 32.29%
2021 14.3% -74.9% 238.3% 13.51%
2020 41.2% -44.1% 2474.5% 19.17%
2019 36.7% -50.2% 44.0% 6.24%

Total Return Ranking - Trailing

Period BSGSX Return Category Return Low Category Return High Rank in Category (%)
YTD 8.8% -1.4% 93.8% 84.66%
1 Yr 8.8% -2.3% 102.5% 85.05%
3 Yr -4.4%* -15.1% 30.0% 87.84%
5 Yr 8.2%* -2.2% 101.1% 68.06%
10 Yr N/A* 2.3% 24.3% N/A

* Annualized

Total Return Ranking - Calendar

Period BSGSX Return Category Return Low Category Return High Rank in Category (%)
2023 10.6% -26.1% 68.0% 95.33%
2022 -27.3% -67.0% 56.8% 46.58%
2021 18.1% -23.5% 342.2% 24.19%
2020 43.9% 2.6% 2549.1% 32.71%
2019 36.7% 14.6% 44.8% 31.18%

NAV & Total Return History


BSGSX - Holdings

Concentration Analysis

BSGSX Category Low Category High BSGSX % Rank
Net Assets 182 M 2.73 M 100 B 81.20%
Number of Holdings 62 24 3569 71.71%
Net Assets in Top 10 47.2 M 635 K 11.9 B 83.14%
Weighting of Top 10 25.82% 4.9% 97.8% 46.12%

Top 10 Holdings

  1. Shift4 Payments Inc 2.82%
  2. Kadant Inc 2.81%
  3. Descartes Systems Group Inc/The 2.71%
  4. First American Government Obligations Fund 2.71%
  5. Kinsale Capital Group Inc 2.64%
  6. Insulet Corp 2.58%
  7. Clearwater Analytics Holdings Inc 2.50%
  8. Watsco Inc 2.40%
  9. AAON Inc 2.36%
  10. Pool Corp 2.29%

Asset Allocation

Weighting Return Low Return High BSGSX % Rank
Stocks
97.34% 58.72% 103.99% 72.29%
Cash
2.71% 0.00% 32.84% 28.49%
Preferred Stocks
0.00% 0.00% 6.15% 62.79%
Other
0.00% -0.11% 14.15% 69.38%
Convertible Bonds
0.00% 0.00% 0.40% 56.01%
Bonds
0.00% 0.00% 2.73% 59.88%

Stock Sector Breakdown

Weighting Return Low Return High BSGSX % Rank
Technology
30.15% 0.04% 62.17% 59.11%
Healthcare
25.60% 0.00% 37.06% 7.56%
Industrials
22.88% 0.00% 38.23% 5.62%
Consumer Cyclical
11.69% 0.00% 57.41% 69.77%
Financial Services
2.33% 0.00% 43.01% 91.28%
Real Estate
2.32% 0.00% 19.28% 52.91%
Energy
2.30% 0.00% 62.10% 41.09%
Consumer Defense
1.54% 0.00% 16.40% 64.15%
Communication Services
1.18% 0.00% 18.33% 72.87%
Utilities
0.00% 0.00% 12.94% 67.05%
Basic Materials
0.00% 0.00% 17.25% 89.53%

Stock Geographic Breakdown

Weighting Return Low Return High BSGSX % Rank
US
97.34% 46.79% 103.99% 61.63%
Non US
0.00% 0.00% 33.15% 67.25%

BSGSX - Expenses

Operational Fees

BSGSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.17% 0.02% 17.54% 39.73%
Management Fee 0.75% 0.00% 1.50% 58.25%
12b-1 Fee 0.25% 0.00% 1.00% 48.06%
Administrative Fee N/A 0.00% 0.40% N/A

Sales Fees

BSGSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

BSGSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BSGSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 50.00% 0.00% 250.31% 60.65%

BSGSX - Distributions

Dividend Yield Analysis

BSGSX Category Low Category High BSGSX % Rank
Dividend Yield 0.00% 0.00% 33.43% 65.31%

Dividend Distribution Analysis

BSGSX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annual SemiAnnual Annual

Net Income Ratio Analysis

BSGSX Category Low Category High BSGSX % Rank
Net Income Ratio -0.88% -2.24% 2.75% 74.80%

Capital Gain Distribution Analysis

BSGSX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Semi-Annually Annually

Distributions History

View More +

BSGSX - Fund Manager Analysis

Managers

Jonathan Good


Start Date

Tenure

Tenure Rank

Oct 31, 2018

3.58

3.6%

Jonathan joined Baird in 2006 and has 18 years of investment experience. He is currently the Portfolio Manager for the Small/Mid Cap Growth strategy and a Senior Research Analyst covering healthcare for the growth strategies. Before joining Baird Equity Asset Management, Jonathan worked at Gartmore Global Investments as an equity analyst for their Global Health Sciences Fund. Prior to joining Gartmore, he spent five years at William Blair & Company as an equity research associate covering Biotech, Lifesciences, Diagnostics and Orthopedics. Jonathan earned a degree in Applied and Biomedical Sciences from the University of Pennsylvania, and earned his MBA from the Kellogg School of Management at Northwestern University.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.04 36.3 9.42 11.76